Author: Zacks Small Cap Research

12344520 / 450 POSTS
By Ian Gilson, PhD, CFANASDAQ:MBII | NYSE:CMPREAD THE FULL MBII RESEARCH REPORTMarrone Bio (NASDAQ:MBII) has formed a collaboration with Compass Minerals Plant Nutrition (NYSE:CMP) to develop new plant nutrition products (enhanced fertilizers) that a ...
By Lisa ThompsonNASDAQ:NETEREAD THE FULL NETE RESEARCH REPORTIn the first quarter of 2019, Net Element (NASDAQ:NETE) improved its margins significantly despite reporting down revenues for the very first time in its history. As a sign of improving pro ...
By Lisa ThompsonNASDAQ:TSEMREAD THE FULL TSEM RESEARCH REPORTTowerJazz (NASDAQ:TSEM) reported Q1 2019 revenues of $310 million versus $313 million a year ago (down 1%), exactly in the midpoint of its guidance range. The industry is still suffering fr ...
By Brian Marckx, CFANASDAQ:ICADREAD THE FULL ICAD RESEARCH REPORTQ1 2019 Results: Therapy Buoys Q1 Sales, Benefits Operating Loss. Detection Acceleration Still Expected in 2H…iCAD (NASDAQ:ICAD) reported financial results for their first quarter and p ...
By Lisa ThompsonNASDAQ:MOGOREAD THE FULL MOGO RESEARCH REPORTMogo (NASDAQ:MOGO) reported revenues for the first quarter of 2019 of $16.4 million versus $14.3 million a year ago up 14% and ahead of our expectations. The beat was mostly in higher inter ...
By David Bautz, PhDTSX:MDNA.TO | OTC:MDNAF READ THE FULL MDNA.TO RESEARCH REPORTWe are initiating coverage of Medicenna Therapeutics Corp. (TSX:MDNA.TO) (OTC:MDNAF) with a valuation of $3.50. Medicenna is a clinical stage immunotherapy company develo ...
By Brian Marckx, CFANASDAQ:MNKDREAD THE FULL MNKD RESEARCH REPORTQ1 2019 Update: Product Sales Up 49% on 71% Growth in Demand. Product Margin Continues to Expand..MannKind (NASDAQ:MNKD) reported financial results for their first quarter ending March ...
By David Bautz, PhDNASDAQ:SPHSREAD THE FULL SPHS RESEARCH REPORTBusiness UpdateSophiris Bio Inc. (NASDAQ:SPHS) is developing treatments for localized clinically significant prostate cancer and lower urinary tract symptoms of benign prostatic hyperpla ...
By Ian Gilson, PhD, CFANASDAQ:EASTREAD THE FULL EAST RESEARCH REPORTEastside Distilling (NASDAQ:EAST) announced it 1Q19 results on May 13, 2019 followed by a conference call.Revenue was slightly higher than expected ($3.7 million actual versus $3.5 m ...
By David Bautz, PhDNASDAQ:DFFNREAD THE FULL DFFN RESEARCH REPORTBusiness UpdatePhase 2 Trial of TSC in Stroke to Initiate in 2019Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) is currently planning to conduct the Pre-Hospital Ambulance Stroke Trial – ...
12344520 / 450 POSTS